Guoping Da, an IP litigator and counselor, represents multinational companies in IP enforcement and infringement actions in the United States and China. These representations have involved a broad range of technologies such as biotechnology, pharmaceuticals, animal health products, optics, computer hardware and software, and vehicle telematics. Guoping also has extensive experience in the area of trade secrets, and she published an article regarding strategies for trade secret protection in China.
Guoping is experienced in assisting clients in technology transfer transactions. Her recent representative experience includes: Incyte's strategic collaboration and license agreement with Innovent for the China rights of certain clinical stage pharmaceutical candidates; Incyte's sublicense out to Zai Lab of certain intellectual property rights in China to an anti-PD1 molecule; and Huadong Medicine's subscription of Series B preferred shares of R2 Dermatology and the distribution agreement between R2 and Huadong regarding a medical device product.
Guoping also assists multinational companies on compliance and corruption matters. Her experience includes advising clients on Foreign Corrupt Practices Act (FCPA) issues and conducting related investigations, providing compliance training for clients operating in China, and conducting anticorruption due diligence for inbound investment.
Guoping's Ph.D. thesis focused on structure determination and function characterization of gene regulatory proteins, including histone deacetylases and histone demethylases. As such, she is familiar with a broad range of molecular, biochemical, and biophysical research tools centered around X-ray crystallography and structure-based drug design.
Experience
Speaking Engagements
- 2016年1月18日
知识产权研讨会——专利流氓诉讼的费用转移策略与并购交易中的知识产权审查 - January 18, 2016
Fee Shifting Strategies for Patent Troll Litigation and IP Review in M&A Transactions - 2016年1月18日
知識產權研討會——專利流氓訴訟的費用轉移策略與併購交易中的知識產權審查
- Baylor University (J.D. magna cum laude 2009; Technical Editor, Senior Notes and Comments Editor, Baylor Law Review); University of Pennsylvania (Ph.D. in Biochemistry 2006); Beijing University (B.S. in Chemistry 2000)
- Texas and U.S. District Courts for the Eastern and Northern Districts of Texas
- Mandarin and English